Company · CIK 1789972

# Cullinan Therapeutics, Inc.

| CIK | [1789972](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001789972) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | CGEM (Nasdaq) |
| First annual or quarterly report | 2021-03-30 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-295363 | Shelf Effective | 2026-04-28 | 2026-04-28 | 1 |
| 333-279452 | Shelf Effective | 2024-05-16 | 2024-06-04 | 2 |
| 333-270384 | Shelf Effective | 2023-03-09 | 2023-05-18 | 2 |
| 333-251512 | IPO Final prospectus | 2020-12-18 | 2021-01-11 | 6 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-28 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1789972/000119312526183596/0001193125-26-183596-index.htm) Shelf registered | 333-295363 | 0001193125-26-183596 |
| 2024-06-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1789972/999999999524001737/9999999995-24-001737-index.htm) Declared effective | 333-279452 | 9999999995-24-001737 |
| 2024-05-16 | [S-3](https://www.sec.gov/Archives/edgar/data/1789972/000119312524140544/0001193125-24-140544-index.htm) Shelf registered | 333-279452 | 0001193125-24-140544 |
| 2023-05-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1789972/999999999523001468/9999999995-23-001468-index.htm) Declared effective | 333-270384 | 9999999995-23-001468 |
| 2023-03-09 | [S-3](https://www.sec.gov/Archives/edgar/data/1789972/000119312523065343/0001193125-23-065343-index.htm) Shelf registered | 333-270384 | 0001193125-23-065343 |
| 2021-01-11 | [424B4](https://www.sec.gov/Archives/edgar/data/1789972/000119312521005478/0001193125-21-005478-index.htm) Final prospectus | 333-251512 | 0001193125-21-005478 |
| 2021-01-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1789972/999999999521000071/9999999995-21-000071-index.htm) Declared effective | 333-251512 | 9999999995-21-000071 |
| 2021-01-06 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1789972/000119312521003224/0001193125-21-003224-index.htm) Amendment | 333-251512 | 0001193125-21-003224 |
| 2021-01-04 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1789972/000119312521000161/0001193125-21-000161-index.htm) Amendment | 333-251512 | 0001193125-21-000161 |
| 2020-12-28 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1789972/000119312520326964/0001193125-20-326964-index.htm) Amendment | 333-251512 | 0001193125-20-326964 |
| 2020-12-18 | [S-1](https://www.sec.gov/Archives/edgar/data/1789972/000119312520321670/0001193125-20-321670-index.htm) Registration filed | 333-251512 | 0001193125-20-321670 |
| 2020-11-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1789972/000095012320010687/0000950123-20-010687-index.htm) Draft made public | 377-03734 | 0000950123-20-010687 |

[All filings of this company](https://equitycapital.markets/filings?cik=1789972) · [CSV](https://equitycapital.markets/filings.csv?cik=1789972)

---
Source page: https://equitycapital.markets/company/1789972 · Data: U.S. SEC EDGAR · CC BY 4.0